AWKNF Awakn Life Sciences Corp.Stock Price & Overview
$0.190.0074 (+4.17%)9:43 AM 10/04/23
OTCQB | $USD | Delayed
Awakn Life Sciences Corp., a biotechnology company, engages in the researching, developing, operations, and delivering of psychedelic therapeutics to treat addiction and other mental health conditions in the United Kingdom and Europe. The company has a collaboration agreement with the University of Exeter for exploring the use of ketamine-assisted therapy to treat Severe AUD. Awakn Life Sciences Corp. is headquartered in Toronto, Canada.